Medicofarma Biotech (Poland) Today
| MDB Stock | 0.40 0.01 2.56% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Medicofarma Biotech is selling at 0.4 as of the 17th of December 2024; that is 2.56% up since the beginning of the trading day. The stock's lowest day price was 0.4. Medicofarma Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Moving together with Medicofarma Stock
Moving against Medicofarma Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medicofarma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medicofarma Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medicofarma Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology & Medical Research, Healthcare, Computing (View all Sectors) |
Medicofarma Biotech SA (MDB) is traded on Warsaw Stock Exchange in Poland . The company operates under Healthcare sector and is part of Biotechnology & Medical Research industry.
Check Medicofarma Biotech Probability Of Bankruptcy
Medicofarma Biotech Risk Profiles
Although Medicofarma Biotech's alpha and beta are two of the key measurements used to evaluate Medicofarma Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.5 | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.73 | |||
| Risk Adjusted Performance | (0.05) |
Medicofarma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medicofarma Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Additional Tools for Medicofarma Stock Analysis
When running Medicofarma Biotech's price analysis, check to measure Medicofarma Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicofarma Biotech is operating at the current time. Most of Medicofarma Biotech's value examination focuses on studying past and present price action to predict the probability of Medicofarma Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicofarma Biotech's price. Additionally, you may evaluate how the addition of Medicofarma Biotech to your portfolios can decrease your overall portfolio volatility.